博雅生物(300294.SZ)发预减，预计2025年度归母净利润1.05亿元至1.37亿元，同比下降65.62%至73.55%

Core Viewpoint - Boya Bio (300294.SZ) has disclosed its earnings forecast for the year 2025, indicating a significant decline in net profit attributed to shareholders, with expectations of a decrease between 65.62% to 73.55% compared to the previous year [1] Financial Performance - The company anticipates a net profit of between 105 million to 137 million yuan for 2025 [1] - Excluding non-recurring gains and losses, the company expects a net loss ranging from 7.5 million to 15 million yuan [1]